Toy Andrew sold $408K of CLOV
Toy Andrew (Chief Executive Officer) sold 87,798 shares of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) at $4.65 ($0.41M total) on 2026-08-10 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the CEO’s open-market sale details: 87,798 shares at $4.65 totaling $408,260.70, with holdings after the trade and confirmation of a pre-arranged 10b5-1 plan.
Market read
Traders may monitor insider activity for sentiment, but this specific disclosure is unlikely to change the fundamental outlook given the 10b5-1 framing.
What to watch
The article does not state whether other insiders sold/bought around the same time, nor does it provide any new operational or financial guidance.
Background
The article is a primary-source SEC Form 4 insider transaction for Clover Health Investments Corp. (CLOV).
Ticker impact
Clover Health CEO Toy Andrew filed a Form 4 open-market sale of 87,798 shares at $4.65 on 2026-08-10 under a 10b5-1 plan.
Low near-term impact; any reaction is likely limited to sentiment and positioning rather than fundamentals.
The filing provides transaction size, price, and that it is under a pre-arranged 10b5-1 plan, which reduces the signal of new negative information.
Market effects
No clear sector read-through from a single 10b5-1 insider sale.
None indicated.
None indicated.
Counterpoint
Because the sale is explicitly under a pre-arranged 10b5-1 plan, the market may overreact; the disclosure could be routine rather than a bearish signal.
Key entities
- issuerClover Health Investments Corp. /DE
Subject of the Form 4 insider transaction disclosure.
- insiderToy Andrew
CEO and officer/director who sold shares via an open-market sale under a 10b5-1 plan.
